Lisinopril Tablet
Product Images NDC 43063-769

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lisinopril (NDC 43063-769). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

43063769 Label (43063769)

43063769 Label (43063769)
Label for Lisinopril USP 10 mg tablets, packaged as 60 tablets per bottle, manufactured by PD-Rx Pharmaceuticals, Inc. The label includes dosage instructions, lot number D22B88, expiration date 04/2023, and the NDC 43063-769-60. The label advises to keep out of reach of children and to discontinue use if pregnancy is detected.*
FDA Label Image

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)

Chemical Structure (E299d477 A612 4af4 B6aa F5addc8a736d 01)
Chemical structure diagram of Lisinopril dihydrate, showing the molecular arrangement including carbon rings, amine groups, and two molecules of water of hydration.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.